Pathogenesis and therapy of psoriasis

Lowes, Michelle A.; Bowcock, Anne M.; Krueger, James G.
February 2007
Nature;2/22/2007, Vol. 445 Issue 7130, p866
Academic Journal
Psoriasis is one of the most common human skin diseases and is considered to have key genetic underpinnings. It is characterized by excessive growth and aberrant differentiation of keratinocytes, but is fully reversible with appropriate therapy. The trigger of the keratinocyte response is thought to be activation of the cellular immune system, with T cells, dendritic cells and various immune-related cytokines and chemokines implicated in pathogenesis. The newest therapies for psoriasis target its immune components and may predict potential treatments for other inflammatory human diseases.


Related Articles

  • Vasoactive Intestinal Peptide Regulates its Receptor Expression and Functions of Human Keratinocytes via Type I Vasoactive Intestinal Peptide Receptors. Kakurai, Maki; Fujita, Nobuya; Murata, Satoru; Furukawa, Yusuke; Demitsu, Toshio; Nakagawa, Hidemi // Journal of Investigative Dermatology;May2001, Vol. 116 Issue 5, p743 

    Vasoactive intestinal peptide has been suggested to play some roles in inflammatory dermatoses such as atopic dermatitis and psoriasis. The aim of this study is to clarify the precise mechanisms of how vasoactive intestinal peptide is implicated in the pathogenesis of these disorders. We...

  • Association of Drugs with Psoriasis: A Review of Literature. AHAMED, A. R. S.; KHONDKER, L.; KHAN, M. S. I.; TSLAM, K. A. // Journal of Bangladesh College of Physicians & Surgeons;Oct2012, Vol. 30 Issue 4, p211 

    Psoriasis is a common disorder in dermatologic practice. Though its exact etiology is still unknown but there are many internal and external factors contributing to the clinical course of the disease. There are several drugs described in the literature that have been associated with the...

  • Antimicrobial Peptides Human β-Defensins Stimulate Epidermal Keratinocyte Migration, Proliferation and Production of Proinflammatory Cytokines and Chemokines. Niyonsaba, François; Ushio, Hiroko; Nakano, Nobuhiro; Ng, William; Sayama, Koji; Hashimoto, Koji; Nagaoka, Isao; Okumura, Ko; Ogawa, Hideoki // Journal of Investigative Dermatology;Mar2007, Vol. 127 Issue 3, p594 

    Besides their microbicidal functions, human β-defensins (hBD) and LL-37 activate different immune and inflammatory cells, and their expression is enhanced in inflamed skin and cutaneous wound sites. To protect against pathogens, the skin produces antimicrobial peptides including hBDs and...

  • Flurandrenolide tape solves tough psoriatic lesions. Moyer, Paula // Dermatology Times;Dec98, Vol. 19 Issue 12, p10 

    Recommends the use of flurandrenolide tape in individuals with resistant psoriatic lesions. Comparison of response to flurandrenolide tape versus ointment and cream formulations; Percent of patients who exhibited improvements in sites treated with flurandrenolide; Low folliculitis rate; Side...

  • In vivo Study of Skin Mechanical Properties in Psoriasis Vulgaris. Dobrev, H. // Acta Dermato-Venereologica;09/20/2000, Vol. 80 Issue 4 

    The aim of this study was to investigate the mechanical properties of the skin in psoriatic plaques before and after treatment with dithranol and in clinically uninvolved psoriatic skin in comparison with the skin of healthy controls. In total, 82 psoriatic plaques in 19 in-patients and 51...

  • Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. Ashcroft, Darren M.; Li Wan Po, Alain; Williams, Hywel C.; Griffiths, Christopher E.M. // BMJ: British Medical Journal (International Edition);04/08/2000, Vol. 320 Issue 7240, p963 

    Provides information on a study which evaluated the comparative efficacy and tolerability of topical calcipotriol in the treatment of mild to moderate chronic plaque psoriasis. Methods; Results and discussion; Conclusions.

  • Conservative Treatment Advised for Erythrodermic Psoriasis Patients. Kuznar, Wayne // Dermatology Times;May98, Vol. 19 Issue 5, p22 

    Focuses on the conservative therapy for erythrodermic psoriatic patients in the United States. Discussion on erythroderma; Differential diagnosis for psoriasis; Treatment.

  • Adalimumab.  // Reactions Weekly;5/8/2010, Issue 1300, p5 

    The article presents the case of a 50-year-old man who developed bullous pemphigoid (BP) while receiving adalimumab for psoriasis treatment.

  • Impaired PI3K/Akt Activation-Mediated NF-κB Inactivation Under Elevated TNF-α Is More Vulnerable to Apoptosis in Vitiliginous Keratinocytes. Nan-Hyung Kim; Jeon, Songhee; Lee, Hyun-Joo; Lee, Ai-Young // Journal of Investigative Dermatology;Nov2007, Vol. 127 Issue 11, p2612 

    Levels of the cytokines IL-6, IL-1α, and tumor necrosis factor-α (TNF-α) are significantly higher in lesional than in non-lesional skin of patients with vitiligo. However, how cytokines affect pigmentation is not fully understood. To examine the mechanism, Western blot analysis with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics